Compounds > 5,8,11,14-eicosatetraynoic acid
Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and EHS Tumor

5,8,11,14-eicosatetraynoic acid has been researched along with EHS Tumor in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cochran, FR1
Baxter, CS1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and EHS Tumor

ArticleYear
Carrageenan-induced suppression of T-lymphocyte proliferation in the rat: abrogation of suppressor factor production by the prostaglandin synthesis inhibitors, indomethacin and ETYA.
    Immunobiology, 1984, Volume: 166, Issue:3

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Carrageenan; Cell Division; Cells, Cultured; Fatty Acids,

1984